1. Home
  2. Labeler Index
  3. Cipla Usa, Inc
  4. 69097-904
  5. NDC Package Code: 69097-904-43 Oseltamivir Phosphate

NDC Package 69097-904-43 Oseltamivir Phosphate

For Suspension Oral - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
69097-904-43
Package Description:
1 BOTTLE in 1 CARTON / 60 mL in 1 BOTTLE
Product Code:
69097-904
Proprietary Name:
Oseltamivir Phosphate
Non-Proprietary Name:
Oseltamivir Phosphate
Substance Name:
Oseltamivir Phosphate
Usage Information:
Oseltamivir is used to treat symptoms caused by the flu virus (influenza). It helps make the symptoms (such as stuffy nose, cough, sore throat, fever/chills, aches, tiredness) less severe and shortens the recovery time by 1-2 days. This medication may also be used to prevent the flu if you have been exposed to someone who already has the flu (such as a sick household member) or if there is a flu outbreak in the community. Talk to your doctor for more details. This medication works by stopping the flu virus from growing. It is not a substitute for the flu vaccine. (See also Notes section.)
11-Digit NDC Billing Format:
69097090443
Billing Unit:
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
NDC to RxNorm Crosswalk:
Product Type:
Human Prescription Drug
Labeler Name:
Cipla Usa, Inc
Dosage Form:
For Suspension - A product, usually a solid, intended for suspension prior to administration.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
OSELTAMIVIR PHOSPHATE 6 mg/mL
Pharmacologic Class(es):
Sample Package:
No
FDA Application Number:
ANDA212858
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
01-16-2023
Listing Expiration Date:
12-31-2025
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 69097-904-43?

The NDC Packaged Code 69097-904-43 is assigned to a package of 1 bottle in 1 carton / 60 ml in 1 bottle of Oseltamivir Phosphate, a human prescription drug labeled by Cipla Usa, Inc. The product's dosage form is for suspension and is administered via oral form.

Is NDC 69097-904 included in the NDC Directory?

Yes, Oseltamivir Phosphate with product code 69097-904 is active and included in the NDC Directory. The product was first marketed by Cipla Usa, Inc on January 16, 2023 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 69097-904-43?

The contents of this package are billed per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.

What is the 11-digit format for NDC 69097-904-43?

The 11-digit format is 69097090443. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-269097-904-435-4-269097-0904-43